Weight Management Pharmaceutical Services
Obesity and Overweight: Definition, causes, prevention
Obese and Overweight patient counseling guidelines
Exercise, Physical activities for obese and overweight people
2. INTRODUCTION
Being Overweight and Obese rank
5th among the leading risks for
global deaths.
According to the WHO, at least
2.8M adults die each year, as a
result of being overweight or
obese.
3. OBESITY in the PHILIPPINES
A 2011 survey by the FNRI,
showed that 22.3% of Filipino
adults are overweight and 6.1% are
obese.
The prevalence of overweight
Filipinos is expected to increase
significantly by 2015.
4. OBESITY WORLDWIDE
In 2011, more than 40 million
children under the age of five were
overweight.
Once considered a high-income
country problem, overweight and
obesity are now on the rise in low-
and middle-income
5. OBESITY WORLDWIDE
More than 30 million overweight
children are living in developing
countries and 10 million in
developed countries.
6. OBESITY: DEFINITION
Overweight and obesity are
defined as abnormal or excessive
fat accumulation that may impair
health.
Body mass index (BMI) is a simple
index of weight-for-height that is
commonly used to classify
overweight and obesity in adults
7. BODY MAS INDEX: DEFINITION
It is defined as a person's weight
in kilograms divided by the square
of his height in meters (kg/m2).
a BMI greater than or equal to 25 is
overweight
a BMI greater than or equal to 30 is
obesity.
8. BODY MAS INDEX: DEFINITION
BMI of 40, or between 35 and 40, or
greater than 50 is considered as
morbidly obese (wherein Bariatric
Surgery is the first-line treatment
option).
10. OBESITY: BMI
BMI provides the most useful
population-level measure of
overweight and obesity as it is the
same for both sexes and for all
ages of adults.
13. WAIST CIRCUMFERENCE
MEASUREMENT:
For Men:
waist circumference of lt 94 cm. –
low
mt 102 cm = very high
For Women:
Waist circumference of lt 80 cm =
low
14. BMI and WAIST CIRCUMFERENCE:
COMBINED
BMI
CLASSIFICATIO
N
WAIST CIRCUMFERENCE CO-
MORBIDITIES
PRESENT
LOW HIGH VERY
HIGH
OVERWEIG
HT
1 2 2 3
OBESITY I 2 2 2 3
OBESITY II 3 3 3 4
OBESITY III 4 4 4 4
15. PATIENT COUNSELING:
1 General advice on healthy weight
and lifestyle
2 Diet and physical activity
3 Diet and physical activity ;
consider medications
4 Diet and physical activity ;
consider medications;
consider surgery
16. PATIENT COUNSELING:
EARLY YEARS (UNDER 5S)
MOVEMENTS OF ANY
INTENSITY
1. “TUMMY TIME”
2. REACHING FOR AND
GRASPING OBJECTS,
PULL/PUSH
3. PARENT AND BABY
SWIM
LESSONS
STRENGHT TRAINING 1. FLOOR-BASED PLAY
2. WATER-BASED PLAY
17. PATIENT COUNSELING:
PHYSICAL ACTIVITY
(UNDER 5S – CHILDREN CAPABLE OF
WALKING)
UNSTRUCTURED
, ACTIVE PLAY
ACTIVITIES INVOLVING
MOVEMENTS OF ALL MAJOR
MUSCLE GROUPS
STRUCTURED,
ACTIVE
PLAY
1. ENERGETIC PLAY
(CLIMBING, BIKE RIDING)
2. ENERGETIC BOUTS OF
ACTIVITY
(RUNNING AND CHASING
GAMES)
3. WALKING/SKIPPING TO SHOPS,
A FRIEND’S HOME, A PARK, TO
AND FROM SCHOOL
18. PATIENT COUNSELING:
PHYSICAL ACTIVITY (5 TO 18
YEARS)
MODERATE
INTENSITY
BIKE RIDING
PLAYGROUND ACTIVITIES
VIGOROUS
INTENSITY
FAST RUNNING
SPORTS (BALL GAMES, SWIMMING)
ZUMBATOMIC ® (5 to 11 years)
ZUMBA® FITNESS (12 to 18 years)
STRENGTH
TRAINING
SWINGING ON PLAYGROUND
EQUIPMENT
HOPPING AND /OR SKIPPING (JUMP
ROPE)
GYMNASTICS
TENNIS
19. PATIENT COUNSELING:
PHYSICAL ACTIVITY (14 TO 69
YEARS)
MODERAT
E
INTENSITY
1. BRISK WALKING
2. JOGGING
3. CYCLING (INDOOR)
VIGOROU
S
INTENSITY
1. RUNNING
2. SPORTS (BALL GAMES , SWIMMING)
3. GROUP EXERCISES (TAE BO, HI-LOW,
STEP)
4. ZUMBA® (FITNESS, GOLD, SENTAO,
AQUA)
STRENGT
H
TRAINING
1. WEIGHT TRAINING
2. CARRYING / MOVING HEAVY LOADS
(DOING GROCERIES)
27. PHARMACOLOGICAL
INTERVENTION: CHILDREN
Drug treatment is generally NOT
recommended for children
younger than 12 years.
Exception: in life threatening co-
morbidities. Prescribing should be
started and monitored only in
specialist pediatric settings.
28. PHARMACOLOGICAL
INTERVENTION: CHILDREN
In children younger than 12 years,
treatment with ORLISTAT is
recommended only if physical co-
morbidities (orthopaedic
problems, sleep apnea) severe
psychological comorbidities are
present.
29. PHARMACOLOGICAL
INTERVENTIONS:
CHILDREN
ORLISTAT (XENICAL, ALLI)
1. Should be prescribed for obesity in
children ONLY by a multicisciplinary
team with expertise in;
a. drug monitoring
b. psychological support
c. behavioral intervention
d. interventions to increase physical activity
and to improve diet
31. PHARMACOLOGICAL
INTERVENTIONS: CHILDREN
ORLISTAT (XENICAL, ALLI)
3. After drug treatment has started
in specialist care, it may be
continued in primary care, if local
circumstances and / or licensing
allow.
32. PHARMACOLOGICAL
INTERVENTIONS: CHILDREN
ORLISTAT (XENICAL, ALLI,
LESOFAT)
3. If it is prescribed for children, a 6-
12 month trial is recommended,
with regular review to assess
effectiveness, adverse effects and
adherence.
4. Withdrawal should be considered
33. PHARMACOLOGICAL
INTERVENTIONS:
ADULTS
1. Should be prescribed only as part
of an overall plan for managing
obesity in adults with;
a. BMI of 28 or more with
associated risk factors
b. BMI of 30 or more
34. PHARMACOLOGICAL
INTERVENTIONS:
ADULTS
2. Drug therapy should be continued
beyond 6 months ONLY if the person
has lost at least 5 of their initial BW
since starting the treatment.
The decision to use longer than 12
months (weight maintenance) should
be made after discussion of potential
benefits and limitations with the
36. SURGICAL INTERVENTIONS:
BARIATRIC SURGERY IN ADULTS
1. Recommended as a treatment
option for people with obesity ;
a. BMI of 40 or more, between 35
and 40 and other significant
disease that COULD BE
improved if they lost weight.
b. Patient is generally fit for
anesthesia and surgery
37. SURGICAL INTERVENTIONS:
BARIATRIC SURGERY IN ADULTS
c. All appropriate non surgical
measures
have been tried, but failed.
d. Patient has been receiving or will
receive intensive management in
a
specialist obesity service.
38. SURGICAL INTERVENTIONS:
BARIATRIC SURGERY IN CHILDREN
1.Should be undertaken ONLY by a
multidisciplinary team that can
provide pediatric expertise in;
a. pre-operative assessment
b. providing information on the
different procedures
c. regular post-operative
assessment
39. SURGICAL INTERVENTION:
BARIATRIC SURGERY IN CHILDREN
d. Management of co-morbidities
e. Psychological support before and
after surgery
f. Providing information on/or
access to plastic surgery
g. Access to suitable equipment and
staff trained to use them
40. OBESITY and OVERWEIGHT:
CO-MORBIDITIES
In Children:
1. hypertension
2. hyperinsulinaemia
3. dyslipidemia
4. type 2 diabetes
5. psychosocial dysfunction
6. exacerbation of conditions
(asthma)
41. OBESITY and OVERWEIGHT:
CO-MORBIDITIES
In Adults:
1. Type 2 Diabetes
2. Hypertension
3. Cardiovascular diseases
4. Dyslipidemia
5. Osteoarthritis
6. Sleep Apnea
42. OBESITY and OVERWEIGHT:
CAUSES
The fundamental cause of obesity
and overweight is an energy
imbalance between calories
consumed and calories expended.
44. OBESITY and OVERWEIGHT:
CAUSES
2. an increase in physical
inactivity due to the increasingly
sedentary nature of many forms of
work, changing modes of
transportation, and increasing
urbanization.
45. OBESITY and OVERWEIGHT:
HEALTH CONSEQUENCES
Cardiovascular diseases (mainly
heart disease and stroke), which
were the leading cause of death in
2008
Diabetes
Musculoskeletal Disorders
(especially osteoarthritis - a highly
disabling degenerative disease of
the joints)
46. WEIGHT MANAGEMENT:
DEFINITION
A set of practices and behaviors
that are necessary to keep one's
weight at a healthful level.
It reflects a change in thinking
about treatment of obesity and
overweight.
47. WEIGHT MANAGEMENT:
DEFINITION
A long-term approach to a healthy
lifestyle.
It includes a balance of;
1. healthy eating
2. physical activity / exercise
to equate energy expenditure and
48. WEIGHT MANAGEMENT:
EVIDENCE
Most evidence suggests that the
main reason for the rising
prevalence of overweight and
obesity is a combination of;
1. less active lifestyles
2. changes in eating patterns
49. “CHOOSING HEALTH” White
Paper (2004)
Commitment:
To halt the year-on-year rise in
obesity among children under 11 by
2010, in the context of broader
strategy to tackle obesity in the
population as a whole.
53. NHS CANCER PLAN (DH
2000)
Sets targets to;
1. increase access fruits and
vegetables
2. the consumption of fruits and
vegetables
54. OUR HEALTH, OUR CARE, OUR
SAY:
(WHITE PAPER 2006)
It emphasizes greater service
integration with a wider access to
services closer to patients’ homes.
56. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE DESCRIPTION
(Pharmacy Staff)
1. Initiate discussions with adults
(who appear to be overweight)
about the risks of overweight and
obesity.
57. PATIENT COUNSELING:
Advises to patient must be tailored
to address personal barriers;
1. cost
2. personal tastes
3. availability
4. time
5. views of family / community
members
58. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE DESCRIPTION (Pharmacy
Staff)
3. A risk assessment will be
undertaken to those who consent.
4. Appropriate advice and support
will be provided to those at risk of ill
59. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE DESCRIPTION (Pharmacy
Staff)
5. People at risk from overweight /
obesity and co-morbidities will be
referred to their general practice for
further assessment, support and
disease management.
60. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE DESCRIPTION (Pharmacy
Staff)
6. People who fall within the national
criteria for vascular risk assessment
will be referred for screening.
61. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
AIMS and INTENDED SERVICE
OUTCOMES
1. To raise awareness among
individuals and their families of the
health problems associated with
overweight and obesity, so they can
take more responsibility for their
own health.
62. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
AIMS and INTENDED SERVICE
OUTCOMES
2. To improved diet and nutrition,
promote healthy weight and
increase levels of physical activity
in overweight or obese people.
63. STRATEGY:
FOR SENIOR MANAGERS/ BUDGET
HOLDERS
1. on-site catering should promote
healthy food and drink choices ( by
posters, pricing and positioning of
products).
2. provide policies, facilities and
information that promote physical
activity (secure bicycle parking,,
sign posting, improved decor to
encourage use of stairs.)
64. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
AIMS and INTENDED SERVICE
OUTCOMES
3. To reduce obesity levels in people
who have a BMI greater than 30 (or
> 28 in patients with Asian
ethnicity).
65. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
AIMS and INTENDED SERVICE
OUTCOMES
4. To retain XX% of people for full
duration of the agreed personal
program and to support them in
achieving a 5% to 10% weight loss.
66. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
AIMS and INTENDED SERVICE
OUTCOMES
5. To improve choice and access to
overweight and obesity
management services in primary
care.
67. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
AIMS and INTENDED SERVICE
OUTCOMES
6. To provide targeted advice and
referrals to people with chronic or
longstanding overweight / obesity.
68. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
1. Pharmacy staff will identify adults
who appear overweight and
proactively initiate a discussion
with the person about weight
management, using literature that
highlights the health risks of
overweight and obesity.
69. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
2. Where consent is given;
a. BMI and waist measurements will
be taken.
b. Relevance of the resulting
classification, its long-term problem
/effects in health will be explained.
70. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
2. Where consent is given;
c. Referral from other health care
professionals (via Medicines Use
Review Service) and self-referral will
be the alternative routes to access
the service.
71. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
3. People who consent to a
consultation about weight and other
risk factors for vascular disease will
be invited to do so with a pharmacy
staff member.
72. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
4. The consultation will assess
lifestyle, co-morbidities and
willingness to change.
73. HELPFUL GUIDELINES DURING
PATIENT CONSULTATIONS:
Assess the patient’s view of their
weight and diagnosis, and
possible reasons for weight gain.
Explore eating patterns and
physical activity levels.
Explore disbeliefs about eating,
physical activity, weight gain that
are unhelpful, if the patient wants
to los weight.
74. HELPFUL GUIDELINES DURING
PATIENT CONSULTATIONS:
Be aware that certain ethnic and
socio-economic backgrounds may
be at greater risk of obesity.
Find out what the patient has
already tried and how successful
/unsuccessful it has been, and
what they learned from the
experience.
75. HELPFUL GUIDELINES DURING
PATIENT CONSULTATIONS:
Assess readiness to adopt
changes.
Assess confidence in making
changes.
Patients and their families should
be informed on the reasons for
tests, how tests are performed,
76. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
5. Using the results of the
consultation, an assessment of
whether the person is eligible to
receive further support from the
pharmacy will be made.
77. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
6. For those people who are eligible
for further support from the
pharmacy, will be offered to
encourage;
a. increased physical activity
b. improved eating behavior
78. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
7. Relevant information on the ff.
topics will be provided:
a. overweight and obesity, health-
related risks.
b. realistic targets for weight loss
79. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
8. Discussion with the person will be
documented and a copy of the
agreed goals and actions will be
given to the person.
80. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
9. Follow-up consultations will be
provided for ongoing support and
motivation, and to monitor progress
(up to 6 months).
81. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
10. The person’s spouse / partner
should also be encouraged to los
weight ( if they are both overweight /
obese)
11. Pharmacies will offer user-
friendly, non-judgmental, client-
82. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
12. The part of the pharmacy used for
provision for consultation will
provide a sufficient level of privacy
and safety.
83. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
13. Pharmacy contractor has a duty
to ensure that pharmacists and staff
involved in the provision of the
service have;
a. relevant knowledge
b. appropriately trained in the operation
of the service ( sensitive, client-
centered communication skills)
84. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
14. Pharmacy contractor has a duty
to ensure that pharmacists and staff
involved in the provision of the
service are aware of and operate
within protocols.
85. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
15. Pharmacy must maintain
appropriate records to ensure
effective ongoing service delivery
and audit.
Records will be confidential and
should be stored securely and for a
length of time in line with NHS
record retention policies.
86. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
SERVICE OUTLINE
16. Pharmacists may need to share
relevant information with other
health care professionals and
agencies, in line with local and
national confidentiality
arrangements, including, where
appropriate, the need for the
permission of the person to share
87. REQUIRED SKILLS /TRAININGS
FOR THE
HEALTHCARE PROFESSIONAL
Health benefits and potential
effectiveness of interventions to
prevent obesity, increase activity
levels, improve diet, reduce energy
intake.
Best practice approaches in
delivering such interventions,
including tailoring support to meet
88. REQUIRED SKILLS /TRAININGS
FOR THE
HEALTHCARE PROFESSIONAL
Use of motivational and
counseling techniques.
Need to address barriers to health
professionals providing support
and advice (concerns about
effectiveness of interventions,
patient’s receptiveness, impact of
advice with patients).
89. PHARMACEUTICAL CARE
DELIVERY:
Interventions to increase physical
activity should focus on activities
that fit easily into patient’s
everyday life.
Interventions should be tailored to
patient’s individual preferences
and circumstances.
90. PHARMACEUTICAL CARE
DELIVERY:
Interventions should aim to
improve patient’s belief in their
ability to change;
1. verbal persuation
2. modelling exercise behavior
3. discussing positive effects
91. PHARMACEUTICAL CARE
DELIVERY:
Ongoing support (including
appropriate written materials)
should be given “in person” or by
phone, mail or internet.
Interventions may include
promotional, awareness –raising
activities.
92. PHARMACEUTICAL CARE
DELIVERY:
Discuss weight, diet and activity with
people at times when weight gain is
more likely.
All actions aimed at preventing
excess weight gain and improving
diet and activity levels in children
and young people should actively
include parents and caregivers.
93. WHEN TO CONSIDER REFERRAL
TO A SPECIALIST:
The underlying causes of overweight
and obesity needs to be assessed.
The patient has complex disease
states (which cannot be managed in
primary or secondary care).
Conventional treatment has failed in
primary or secondary care.
94. WHEN TO CONSIDER REFERRAL
TO A SPECIALIST:
Drug Therapy is being considered
for a person with BMI of more than
50.
Specialist interventions may be
needed (very low calorie diet)
Surgery is being considered.
95. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
QUALITY INDICATORS
1. The pharmacy has appropriate DH
provided health promotion materials
available and a suitable area within
the pharmacy for display of these
materials.
96. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
QUALITY INDICATORS
2. The pharmacy reviews its SOP’s
and referral pathways for the
service on an annual basis.
3. The pharmacy participates in an
annual organized audit of service
provision.
97. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
QUALITY INDICATORS
4. The pharmacy cooperates with any
DH-led assessment of service user
experience.
5. The pharmacy can demonstrate
that pharmacists and staff involved
in the provision of service have
undertaken CPD relevant to this
98. PHARMACEUTICAL CARE
SERVICES FOR WEIGHT
MANAGEMENT
QUALITY INDICATORS
6. The pharmacy can demonstrate
robust quality assurance for any
processes or equipment used.
6/9/2013
99. REFERENCES:
NHS Community Pharmacy Contractual Framework
Enhanced Service – Weight Management Service
(adults and children)
National Institute for Health Care and Expertise
Obesity: Guidance on the Prevention, identification,
assessment, and management of overweight and
obesity in adults and children
http://www.nice.org.uk/guidance/CG43/
http://www.dg.gov.uk/obesity/
http://www.doh.org//
Club New You - Xenical
http://www.wikipedia.org/
100. REFERENCES:
Fact Sheet 5: Physical Activity Guidelines for Older
People (69+ years)
Fact Sheet 4: Physical Activity Guidelines for Adults
(19 to 69 years).
Fact Sheet 3: Physical activity Guidelines for
Children and Young People (5 to 18 years)
Fact Sheet 2: Physical activity Guidelines for
Children below 5s
http://www.zumba.com/
In addition, 44% of the diabetes burden, 23% of the ischaemic heart disease burden and between 7% and 41% of certain cancer burdens are attributable to overweight and obesity.
Which means more health problems ahead. If this trend continues, it is highly likely that more will suffer from high risk diseases that could lead to death.
Childhood obesity is associated with a higher chance of obesity, premature death and disability in adulthood. But in addition to increased future risks, obese children experience breathing difficulties, increased risk of fractures, hypertension, early markers of cardiovascular disease, insulin resistance and psychological effects.
Overweight and obesity are linked to more deaths worldwide than underweight. For example, 65% of the world's population live in countries where overweight and obesity kill more people than underweight (this includes all high-income and most middle-income countries).Many low- and middle-income countries are now facing a "double burden" of disease.While they continue to deal with the problems of infectious disease and under-nutrition, they are experiencing a rapid upsurge in noncommunicable disease risk factors such as obesity and overweight, particularly in urban settings.It is not uncommon to find under-nutrition and obesity existing side-by-side within the same country, the same community and the same household.Children in low- and middle-income countries are more vulnerable to inadequate pre-natal, infant and young child nutrition At the same time, they are exposed to high-fat, high-sugar, high-salt, energy-dense, micronutrient-poor foods, which tend to be lower in cost but also lower in nutrient quality. These dietary patterns in conjunction with lower levels of physical activity, result in sharp increases in childhood obesity while undernutrition issues remain unsolved.
However, it should be considered a rough guide because it may not correspond to the same degree of fatness in different individuals.BMI MAY BE LESS ACCURATE MEASURE OF ADIPOSTY IN ADULTS WHO ARE HIGHLY MUSCULAR, SO INTERPRETATION IN THIS GROUP MUST ME WITH CAUTION. SOME POPULATION GROUPS HAVE CO-MORBIDITY RISK FACTORS THAT WOULD BE A CONCERN AT DIFFERENT BMIs (LOWER IN ASIAN ADULTS AND HIGHER FOR OLDER PEOPLE).CLINICAL JUDGMENT MUST BE USE
THE APPROACH SHOULD BE ADJUSTED, AS NEEDED, DEPENDING ON THE PATIENT’S CLINICAL NEED AND POTENTIAL TO BENEFIT FROM LOSING WEIGHT.IN OBESE CHILDREN,ASSESSMENT OF COMORBIDITY SHOULD BE CONSIDERED WTH A BMI AT OR ABOVE THE 98TH CENTILE.
For infants who are NOT YET WALKING.PHYSICAL ACTIVITYSHOULD BE ENCOURAGED FROM BIRTH, PARTICULARLY THROUGH FLOR AND WATER-BASED ACTIVITIES IN SAFE ENVIRONMENTS.
CHILDREN OF PRESCHOOL AGE SHOULD BE PHYSICALLY ACTIVE DAILY FOR AT LEAST 180 MINS (3 HOURS) SPREAD THROUGHOUT THE DAY.SHOULD MINIMIZE BEING SEDENTARY FOR EXTENDED PERIODS, EXCEPT TIME SPENT IN SLEEPING.
STRENGTH TRAINING – FOR THE MUSCLES AND BONESCHILDREN SHOULD ENGAGE IN MODERATE TO VIGOROUS INTENSITY ACTIVITY FOR AT LEAST 60 MINS. UP TO SEVERAL HOURS A DAY. STRENGTH TRAINING SHOULD BE INCORPORATED AT LEAST 3 DAYS A WEEK.
MODERATE INTENSITY – CAUSE ADULTS TO GET WARMER, BREATHE HARDER AND HEARTS TO BEAT FASTER, AND STILL CARRY ON A CONVERSATION.VIGOROUS INTENSITY – ADULS GET WARMER, HEARTS BEAT FASTER, MAKING IT MOR EDIFFICULT TO CARRY ON A CONVERSATIONSTRENGTH TRAINING – WORKS AGAINST RESISTNCE TO STRENGTHEN THE MUSCLE. MUST INVOLVE ALL MAJOR MUSCLE GROUPSOVER A WEEK, ACTIVITY SHOULD ADD UP TO AT LEAST 150 MINUTES (2.5 HOURS) OF MODERATE INTENSITY ACTIVITY, IN BOUTS OF 20 TO 30 MINS,. ON AT LEAST 5X A WEEK. OR 75 MINS. OF VIGOROUS INTENSTIY SPREAD ACROSS THE WEEK OR COMBINATIONS OF MODERATE AND VIGOROUS INTENSITY ACTIVITY.ADULTS SHOULD TAKE STRENGTH TRAINING ON AT LEAST 2 DAYS A WEEK. AND SHOULD MINIMIZE THE AMOUNT OF TIME SPENT BEING SEDENTARY FOR EXTENDED PERIODS.
75 minutes OF VIGOROUS ACTIVITY SPREAD ACROSS THE WEEK, OR A COMBINATION OF MODERATE TO VIGOROUS ACTIVITYMUSCLE STRENGHTENING ACTIVITIES ON AT LEST 2 DAYS A WEEK. OLDER ADULTS AT RISK OF FALLS SHOULD INCORPORATE BALANCE AND COORDINATION ACTIVITIES ON AT LEAST 2 DAYS A WEEK.
TREATENT SHOULD BE STARTED IN A SPECIALIST PEDIATRIC SETTING, BY MULTIDISCIPLINARY TEAMS WITH EXPERIENCE WITH THIS AGE GROUP.
PRE-OPERATIVE ASSESSMENT – RISK BENEFIT ANALYSIS, PREVENTION OF COMLICATIONS, SPECIALIST ASSESSMENT FOR EATING DISORDERSPOST-OPERATIVE ASSESSMENT – SPECIALIST DIETETIC AND SURGICAL FOLLOWUP.
EQUIPMENT – SCALES. THEATRE TABLES, PRESURE RELIEVING MATRESS, ZIMMER BED FRAMES, HOISTS AND SEATING.ALL YOUNG PEOPLE SHOULD HAVE HAD A COMPREHENSIVE PSYCHOLOGICAL, EDUCATION, FAMILY AND SOCIAL ASSESSMENT BEFORE AND AFTER SURGERY.A FULL MEDICAL EVALUATION INCLUDING GENERIC SCREENIG SHOUD BE MADE BEFOR ESURGERY TO RULE OUT RARE, TREATABLE CAUSES OF OBESITY.
LIFE THREATENING CO-MORBIDITIES IN CHILDREN INCLUDE SLEEP APNEA AND INCREASED INTRACRANIAL PRESSURE).THE REQUIRED TESTS FOR CHILDREN: BP MEASUREMENT, FASTING LIPID PROFILE, FASTING INSULIN AND GLUCOSE LEVELS, LIVER FUNCTION, ENDOCRINE FUNCTION
Changes in dietary and physical activity patterns are often the result of environmental and societal changes associated with development and lack of supportive policies in sectors such as health, agriculture, transport, urban planning, environment, food processing, distribution, marketing and education.
Raised BMI is a major risk factor for noncommunicable diseases such as:The risk for these noncommunicable diseases increases, with the increase in BMI.
It is preferred to the term "dieting," because it involves more than regulation of food intake or treatment of overweight people. People diagnosed with eating disorders who are not obese or overweight still need to practice weight management. Some health care professionals use the term "nutritional disorders" to cover all disorders related to weight.Before 1980, treatment of overweight people focused on weight loss, with the goal of helping the patient reach an "ideal weight" as defined by standard life insurance height-weight charts. In recent years, however, researchers have discovered that most of the negative health consequences of obesity are improved or controlled by a relatively modest weight loss, perhaps as little as 10% of the patient's body weight. It is not necessary for the person to reach the "ideal" weight to benefit from weight management. Some nutritionists refer to this treatment goal as the "10% solution." Secondly, the fact that most obese people who lose large amounts of weight from reduced-calorie diets regain it within five years has led nutrition experts to emphasize weight management rather than weight loss as an appropriate outcome of treatment.
Both of these factors must be tackled to produce reductions in obesity. Even a modest loss of 5 to 10% body weight in an obese of overweight persons can result in health and well being benefits.
This is monitored through a national public service agreement target.
NSF = NATIONAL SERVICE FRAMEWORK
This White Paper is an important newstage in building a world-class healthand social care system. It meets thehealth challenges of the new century,and adapts to medical advances whileresponding to demographic changes inour society and increasing expectationsof convenience and customer servicefrom the public who fund the healthservice. These proposals, part of theGovernment’s wider reformprogramme, will allow us to acceleratethe move into a new era where theservice is designed around the patientrather than the needs of the patientbeing forced to fit around the servicealready provided.This White Paper builds on theseprinciples and the significant progress,achieved through increased investmentand reform, within the NHS over thelast few years. There are 79,000 morenurses and 27,000 more doctors thanin 1997 with more in training. Waitinglists and waiting times are dramaticallydown, helped in part by giving patientsmore choice and encouraging newproviders within the NHS. Theflexibility and freedoms offered tofoundation hospitals have helped themimprove care and service.Deaths from cancer have fallen by14 per cent, from heart disease by31 per cent. Acute and emergency carein our hospitals has been transformed.Thousands of people in everycommunity owe their lives to theextraordinary medical advances ofrecent decades and to the dedicationof NHS staff.
THIS IS PARTICULARLY IMPORTANT FOR PEOPLE FROM BLACK AND MINORITY ETHNIC GROUPS, PEOPLE IN VULNERABLE GROUPS (LOW-INCOME FAMILIES), PEOPLE AT LIFE STAGES WITH INCREASED RISK FOR WEIGHT GAIN (PREGNANCY, MENOPAUSE, SMOKING CESSATION).
LITERATURE AND PROMOTIONAL MATERIALS AVAILABLE IN THE PHARMACY WILL SUPPORT THESE INTERVENTIONS.
PEOPLE WHO DO NOT WISH TO DISCUSS FURTHER WILL BE INVITED TO RETURN FOR FURTHER SUPPORT, SHOULD THEY CHANGE THEIR MIND AND THE WILL BE GIVEN COPY OF THE DH WHY WEIGHT MATTERS CARD.
INCLUDING’PRESENTING SYMPTOMS AND UNDERLYING CAUSES OF OVERWEIGHT AND OBESITYEATING BEHAVIORRISK FACTORS and CO MORBIDITIES – TYPE 2 DIABETES, HTN, CVD, DYSLIPIDEMIA, OA, SLEEP APNEALIFESTYLE – DIET AND PHYSICAL ACTIVITY PSYCHOSOCIAL DISTRESSFAMILY HISTORY, ENVIRONMENTAL, SOCIAL AND FAMILY FACTORSMOTIVATION / WILLINGNESS TO CHAGEPOTENTIAL OF WEIGHT LOSS TO IMPROVE HEALTHPSYCHOLOGICAL PROBLEMSMEDICAL PROBLEMS AND MEDICATIONSURPRISE, ANGER, DENIAL OR DISBELIEF MAY DIMINISH PATIENT’S ABILITY OR WILLINGNESS TO CHANGE. STRESSING THATOBESITY IS A CLINICAL TERM WITH SPECIFIC HEALTH IMPLICATIONS, RATHER THAN A QUESTION FO HOW YOU LOOK, MAYHELP TO MITIGATE THIS PROBLEM.
ANOTHER CONSULTATION SHOULD BE OFFERED TO FULLY EXPLORE THE OPTIONS FOR TREATMENT AND DISCUSS TEST RESULTS.TESTS SHOULD INCLUDE, LIPD PROFILE, FBS, BP MEASUREMENT.
IF PERSON EXHIBITS ANY SYMPTOMS INDICATIVE OF UNDIAGNOSED PATHOLOGY, THEY WILL BE REFERRED TO THEIR GP. PEOPLE WHO FALL WITHIN THE NATIONAL CRITERIA FOR VASCULAR RISK ASSESSMENT WILL BE REFERRED FOR SCREENING.
THESE INTERVENTIONS WILL BE TAILORED TO THE INDIVIDUAL’S PREFERENCES, SOCIAL CIRCUMSTANCES, DEGREE OF OVERWEIGHT / OBESITY, ANY PREVIOUS INTERVENTIONS AND LEVEL OF RISK.
IN LINE WITH THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) B. MAX LOSS OF 0.5 TO 1 KG / WEEK AIM TO LOSE 5 TO 10% OF THE ORIGINAL BW THE IMPORTANCE OF DEVELOPING SKILLS FOR BOTH LOSING AND MAINTAINING LOST WEIGHT REALISTIC TARGETS FOR PHYSICAL ACTIVITY AND HEALTHY EATING HEALTHY EATING SELF CARE VOLUNTARU ORGANIZATION AND SUPPORT GROUPS
AT THE END OF THE SUPPORT PROGRAM, FINAL MEASUREMENTS WILL BE TAKEN AND RECORDED AND ONGOING GOALS WILL BE AGREED WITH THE PERSON.
AT THE LEVEL REQUIRED FOR THE PROVISION OF THE MEDICINES USE REVIEW SERVICE.
BUT THESE SHOULD BE PART OF A LONG –TERM, MULTI-COMPONENT INTERVENTION.